IP Library Granted Patent US 8,696,760
Granted Patent B2
US 8,696,760 · App. 13/037,559 · Granted Apr 15, 2014

Scaffolds for organ reconstruction and augmentation

Inventors: Timothy A. Bertram (Winston-Salem, NC); Andrew Bruce (Lexington, NC); Deepak Jain (Winston-Salem, NC); Manuel J. Jayo (Winston-Salem, NC); John W. Ludlow (Carrboro, NC); Darell McCoy (Clemmons, NC); Richard Payne (Winston-Salem, NC); Namrata D. Sangha (Winston-Salem, NC); Oluwatoyin A. Knight (Winston-Salem, NC)
Assignee: Tengion, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,696,760
App. No.
13/037,559
Granted
Apr 15, 2014
Kind
B2
Abstract

Biocompatible synthetic or natural scaffolds are provided for the reconstruction, repair, augmentation or replacement of organs or tissue structures in a patient in need of such treatment. The scaffolds are shaped to conform to at least a part of the organ or tissue structure and may be seeded with one or more cell populations. Inserts, receptacles and ports are also provided for the attachment of tubular vessels to the neo-organ scaffolds. The seeded scaffolds are implanted into the patient at the site in need of treatment to form an organized organ or tissue structure. The scaffolds may be used to form organs or tissues, such as bladders, urethras, valves, and blood vessels.

Claims (40)

1. An implantable construct comprising:

(a) a first hemispherical matrix and a second hemispherical matrix each having a first surface, a closed end, and an open equatorial border comprising a flanged region, wherein the first matrix and the second matrix are adapted to mate and are shaped to conform to at least a part of a luminal organ when mated, wherein the first matrix, the second matrix, or both, are each adapted to receive a native vessel, and wherein the flanged region of the first matrix is adapted to mate with the flanged region of the second matrix; and

(b) a first cell population deposited on or in said first surface of the first matrix and on or in said first surface of the second matrix to form an implantable construct, wherein said first cell population comprises a muscle cell population, said matrices and said cell population forming an implantable construct.

2. The construct of claim 1 , wherein the first matrix, the second matrix, or both, further comprise at least one receptacle.

3. The construct of claim 2 , wherein the at least one receptacle is adapted to receive a tubular insert.

4. The construct of claim 3 , further comprising a tubular insert which is disposed within said at least one receptacle, wherein the tubular insert has an end.

5. The construct of claim 4 , the tubular insert having at least one flange located at said end.

6. The construct of claim 4 , wherein the tubular insert is adapted to connect to a native vessel.

7. The construct of claim 5 , further comprising a surface and a washer disposed around the tubular insert.

8. The construct of claim 7 , wherein the washer is adapted to form a watertight seal between the flange and the surface of the construct.

9. The construct of claim 7 or 8 , wherein said washer comprises a hydrogel.

10. The construct of claim 1 , wherein the first matrix, second matrix, or both, comprise a biocompatible material.

11. The construct of claim 10 , wherein the biocompatible material comprises a biodegradable material.

12. The construct of claim 1 , wherein the first matrix, second matrix, or both, comprise material selected from the group consisting of polyglycolic acid, polylactic acid and a copolymer of glycolic acid and lactic acid.

13. The construct of claim 1 , wherein the first matrix, second matrix, or both, comprise polyglycolic acid and a copolymer of glycolic acid and lactic acid.

14. The construct of claim 1 , wherein the at least one cell population is a smooth muscle cell population.

15. The construct of claim 1 , said matrices each having a second surface, the construct further comprising a second population of cells deposited on or in said second surface of the first matrix, said second surface of the second matrix, or both.

16. The construct of claim 15 , wherein the second population of cells comprises urothelial cells.

17. The construct of claim 1 , wherein the luminal organ is a genitourinary organ.

18. The construct of claim 17 , wherein the genitourinary organ is selected from the group consisting of bladder, ureters and urethra.

19. The construct of claim 17 , wherein the genitourinary organ is a bladder or a bladder segment.

20. The construct of claim 19 , wherein the implantable construct is adapted to form regenerated bladder tissue in vivo that exhibits the compliance of natural bladder tissue.

21. The construct of claim 1 , wherein the first matrix has a hemispherical shape having a closed end and an open, equatorial border, and wherein the second matrix comprises a collar adapted to mate with the equatorial border of the first matrix.

22. The construct of claim 21 , said matrices comprising second surfaces, the construct further comprising a second population of cells deposited on or in a second surface of the first matrix, a second surface of the second matrix, or both.

23. The construct of claim 22 , wherein the second population of cells comprises urothelial cells.

24. The construct of claim 23 , wherein one of the first or second population of cells are not deposited on or in the first or second surface of the collar-shaped second matrix.

25. The construct of claim 1 , further comprising a second population of cells deposited on or in a second surface of the first matrix, a second surface of the second matrix, or both.

26. The construct of claim 25 , wherein the second population of cells comprises urothelial cells.

27. The construct of claim 1 , wherein the open equatorial border of the first matrix is adapted to mate with the open equatorial border of the second matrix.

28. The construct of claim 27 , wherein each open equatorial border is a flanged equatorial border.

29. A method for the reconstruction, augmentation or replacement of laminarly organized luminal organs or tissue structures in a patient in need of such treatment comprising implanting the construct of claim 1 into said patient at the site of said treatment for the regeneration of a luminal organ or tissue structure.

30. The method of claim 29 , wherein the first matrix, second matrix, or both, is adapted to receive a native vessel.

31. The method of claim 30 , wherein the first matrix, second matrix, or both, further comprise at least one receptacle.

32. The method of claim 31 , wherein the at least one receptacle is adapted to receive a tubular insert.

33. The method of claim 32 , wherein the first matrix, second matrix, or both, further comprise a tubular insert which is disposed within the at least one receptacle, wherein the tubular insert has an end.

34. The method of claim 33 , the tubular insert having at least one flange located at said end.

35. The method of claim 34 , wherein the tubular insert is adapted to connect to a native vessel.

36. The method of claim 35 , wherein the first matrix, second matrix, or both, further comprise a surface and a washer disposed around the tubular insert.

37. The method of claim 36 , wherein the washer is adapted to form a watertight seal between the flange and the surface of the construct.

38. The method of claim 35 or 36 , wherein said washer comprises a hydrogel.

Assignments (3)
SECURITY INTEREST Recorded Feb 14, 2019
From: ORGAGEN, INC.
To: INREGEN
Reel/Frame 048339/0600 →
ASSIGNMENT OF SECURITY INTEREST Recorded Feb 14, 2019
From: INREGEN
To: EASTERN CAPITAL LIMITED
Reel/Frame 048350/0657 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2019
From: INREGEN
To: ORGAGEN, INC.
Reel/Frame 048255/0914 →
Continuity (3)
Continuation 11706081 · Feb 12, 2007
Provisional Application 60772754 · Feb 10, 2006
Related Publication 20110257726A1 · Oct 20, 2011